BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 18412594)

  • 1. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.
    Garg S; Brod R; Kim D; Lane RG; Maguire J; Fischer D
    Clin Exp Ophthalmol; 2008 Apr; 36(3):252-6. PubMed ID: 18412594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
    Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal pigment epithelial tear after intravitreal bevacizumab injection.
    Shah CP; Hsu J; Garg SJ; Fischer DH; Kaiser R
    Am J Ophthalmol; 2006 Dec; 142(6):1070-2. PubMed ID: 17157598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration.
    Gelisken F; Ziemssen F; Voelker M; Bartz-Schmidt KU; Inhoffen W
    Eye (Lond); 2009 Mar; 23(3):694-702. PubMed ID: 18239678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress].
    Kook D; Wolf A; Neubauer AS; Haritoglou C; Priglinger SG; Kampik A; Ulbig MW
    Ophthalmologe; 2008 Feb; 105(2):158-64. PubMed ID: 17653552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.
    Spandau UH; Jonas JB
    Am J Ophthalmol; 2006 Dec; 142(6):1068-70. PubMed ID: 17157597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD.
    Gutfleisch M; Heimes B; Schumacher M; Dietzel M; Lommatzsch A; Bird A; Pauleikhoff D
    Eye (Lond); 2011 Sep; 25(9):1181-6. PubMed ID: 21701525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal pigment epithelium tears following intravitreal ranibizumab therapy.
    Kiss C; Michels S; Prager F; Geitzenauer W; Schmidt-Erfurth U
    Acta Ophthalmol Scand; 2007 Dec; 85(8):902-3. PubMed ID: 17408387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Avery RL; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ
    Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration.
    Cunningham ET; Feiner L; Chung C; Tuomi L; Ehrlich JS
    Ophthalmology; 2011 Dec; 118(12):2447-52. PubMed ID: 21872935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-VEGF response in macular hemorrhage and incidence of retinal pigment epithelial tears.
    Varshney N; Jain A; Chan V; Yu L; Sarraf D
    Can J Ophthalmol; 2013 Jun; 48(3):210-5. PubMed ID: 23769784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).
    Sarraf D; Joseph A; Rahimy E
    Trans Am Ophthalmol Soc; 2014 Jul; 112():142-59. PubMed ID: 25646033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A; Stinnett S; Fekrat S
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal pigment epithelial tears in ranibizumab-treated eyes.
    Smith BT; Kraus CL; Apte RS
    Retina; 2009 Mar; 29(3):335-9. PubMed ID: 19174716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment.
    Weinberger AW; Thiel M; Mohammadi B; Theofylaktopoulos I; Thumann G; Walter P
    Am J Ophthalmol; 2007 Aug; 144(2):294-6. PubMed ID: 17659961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal pigment epithelial tear after ranibizumab therapy for subfoveal fibrovascular pigment epithelial detachment.
    Chan CK; Lin SG
    Eur J Ophthalmol; 2007; 17(4):674-6. PubMed ID: 17671950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.